In trials

  • MajesticSloth@lemmy.world
    link
    fedilink
    arrow-up
    155
    arrow-down
    1
    ·
    8 months ago

    When this was posted before someone who followed it fairly closely and others like it, updated the thread with info because the article was behind current info. They had already stopped the trials for MS because it wasn’t working. So they began to just focus on one other, the Crohn’s, I believe. Figuring if they got one to work, they could go back to the others and get them on the right track.

    I have MS, and while this is a new approach, there have been so many articles about treatments that end up going nowhere after the first excitement. So it is still very early to get hopes up.

    Hope can be a dangerous thing. Hope can drive a man insane, as Red said.

    • kromem@lemmy.world
      link
      fedilink
      English
      arrow-up
      49
      arrow-down
      2
      ·
      8 months ago

      Is it possible that other person was just full of shit?

      Here was an update posted on Sept 12th, 2023 from the company behind the trials regarding the MS trials:

      Anokion has completed patient enrollment early in the second and final MAD cohort of its MoveS-it (Multiple Sclerosis Study of ANK-700 to Assess Safety and Immune Tolerance) clinical trial to evaluate ANK-700 for the treatment of patients with multiple sclerosis. MoveS-it is a randomized, double-blind, placebo-controlled Phase 1 study evaluating ANK-700 for the treatment of patients with relapsing remitting multiple sclerosis (RRMS). MS is a demyelinating disease of the CNS, in which the immune system attacks the myelin sheath in the brain and spinal cord. RRMS is the most common type of MS, characterized by recurring episodes of new or worsening symptoms. Anokion has designed ANK-700 to re-educate the immune system by inducing antigen-specific tolerance to myelin-based autoantigens to reduce neuroinflammation in the brain and spinal cord.

      Safety data from both the SAD and MAD cohorts supports that ANK-700 is safe and well-tolerated at all dose levels tested through the dose escalation period. Further, preliminary biomarker data from the MAD cohorts displays trends in antigen-specific immune tolerance and evidence of bystander suppression to related myelin antigens, which is critical to treating complex autoimmune diseases like MS.

      The study will continue with a 12-month safety follow-up expected to complete in the first half of 2024. Anokion anticipates reporting full results from its MoveS-it clinical trial in the second half of 2024.

      This says that the single dose (SAD) phase 1 trial which began in 2020 was completed and they moved on to the second multiple ascending dose trial (MAD) for MS which completed enrollment and expect results in 2024. And that the preliminary data from the first MAD trial indicates therapeutic response.

      And the press release talks about how they’ve moved on to a phase 2 trial for its use for celiacs (the initial trial use case). And then on Oct 12th they announced they will be presenting data from their phase 1 for celiacs at a conference.

      A week after the announcement quoted above they released the news about their peer reviewed paper mentioning the early success in both (what likely inspired OP’s article), saying:

      We have now observed our approach play out in the clinic with early data from our lead programs in celiac disease and multiple sclerosis, KAN-101 and ANK-700, that demonstrated antigen-specific tolerance, bystander suppression, and an impact on disease-specific biomarkers.

      None of this looks like a company that has a failing drug on their hands. And there’s no indication of the MS trial being ended early - the only thing that happened early was completing enrollment early.

      Being too ready to give up on hope is its own kind of insanity.

    • evatronic@lemm.ee
      link
      fedilink
      English
      arrow-up
      31
      arrow-down
      2
      ·
      8 months ago

      T1 diabetes here. A cure is just 5 years away…

      They told me, when I was diagnosed in 1992.

      • Lmaydev@programming.dev
        link
        fedilink
        arrow-up
        18
        arrow-down
        1
        ·
        8 months ago

        It always 5 years if properly funded. It’s never properly funded so always 5 years.

        They are testing an artificial pancreas currently. The cost is the issue as always.

        • AnyOldName3@lemmy.world
          link
          fedilink
          arrow-up
          7
          ·
          edit-2
          8 months ago

          We can genetically engineer bacteria to mimic the missing pancreatic cells, and it’s not too different to the way most insulin is produced as all that’s new is the system to stop producing insulin when blood sugars are already low enough. However, if you put them in a person, the immune system attacks the bacteria, so they need isolating. To do that, we need a membrane that lets sugar in and insulin out, but doesn’t let antigens or live bacteria out, and doesn’t let immune cells in. Even if the bacteria are held in place, if immune cells can get in, it’s no better than a pancreatic transplant as you’ll still need immunosuppressants, and they’re generally worse than dealing with type one manually. Development of the membrane keeps hitting unexpected hurdles, so artifical pancreases are still unable to start trials, and then they might take a decade.

          There are other approaches, e.g. using electronics to control photosensitive insulin producing bacteria, but they don’t have any advantages (the membrane still has to let sugar in so the bacteria can eat) and have more things that can go wrong.

    • nul9o9@lemmy.world
      link
      fedilink
      arrow-up
      11
      ·
      8 months ago

      Well damn, I got MS too but caught it fairly early. I’m hoping for a major breakthrough before it gets really bad.

    • stoy@lemmy.zip
      link
      fedilink
      arrow-up
      5
      ·
      8 months ago

      So, if I understand this right, a more accurate title would be “Research into vaccines against autoimmune diseases continues, new data indicate that a change of focus might be needed”

  • FrankTheHealer@lemmy.world
    link
    fedilink
    arrow-up
    43
    ·
    8 months ago

    Website I’ve never heard of: check

    Wild claims that seem too good to be true: check

    Little to no proof about said claims: check

    Don’t get me wrong, this would be fantastic if it’s true. But I’m sceptical. It feels like all those articles about a cure for cancer that then never go anywhere.

  • Son_of_dad@lemmy.world
    link
    fedilink
    arrow-up
    36
    arrow-down
    4
    ·
    8 months ago

    Every science article is just a comment section disapproving the article. That’s why I stay away from these science communities, it’s all clickbait and lies

      • partial_accumen@lemmy.world
        link
        fedilink
        arrow-up
        20
        arrow-down
        1
        ·
        edit-2
        8 months ago

        Easy hack. Get a bunch of more affordable health care services during the year until you reach your out-of-pocket max, then go in and get your 3 million worth of shots all on the insurance company’s dime with zero extra cost to you.

    • BloodSlut@lemmy.world
      link
      fedilink
      arrow-up
      4
      ·
      8 months ago

      This still wont cure diabetes, but it will prevent it from developing or advancing if you catch it early enough.

      • SCB@lemmy.world
        link
        fedilink
        arrow-up
        1
        arrow-down
        1
        ·
        8 months ago

        This doesn’t hold any water, logically.

        If you’re selling insulin and I cure/prevent diabetes with a single treatment t, you no longer have a market and I have literally every human being on the planet.

        Medical science is an arms race, and cures are nukes. You make the best cure, you win. Full stop.

        • sigmaklimgrindset@sopuli.xyz
          link
          fedilink
          arrow-up
          5
          arrow-down
          1
          ·
          edit-2
          8 months ago

          Medical science is an arms race, and cures are nukes. You make the best cure, you win. Full stop.

          You would think that, except pharmaceutical research is rigged towards the few giant corporations that hold the patents. Sure, medical research is an arms race, but who is funding your research? If you find a cure but Pfizer funds you they can patent the cure and bury it or make it cost prohibitive in a variety of different ways.

          The original insulin patent is open. Then why does it cost so much money to get insulin for Americans? Again, corporate patent trolling and controlling the funding for research labs. This is why corporate monopolies need to be regulated.

          (Also I didn’t realize we do downvoting for disagreements on Lemmy now too)

          • SCB@lemmy.world
            link
            fedilink
            arrow-up
            1
            arrow-down
            1
            ·
            edit-2
            8 months ago

            I didn’t downvotes you for a disagreement, but because you’re spreading false conspiracy theories in a science community.

            Also I get downvotes for saying true things people don’t like all the time. It isn’t a big deal.

            • sigmaklimgrindset@sopuli.xyz
              link
              fedilink
              arrow-up
              2
              ·
              8 months ago

              Sure, I’m spreading conspiracy theories. Not like I left chronic disease research and restarted in a completely unrelated field for this exact problem.

              I didn’t work for Pfizer, but I did work for another pharmaceutical company you would recognize the name of if you live in North America. And let me tell you, while the labs are trying to do good, the executives and management are rotten to the core. Unless it’s a life threatening infectious disease, they will not prioritize the research. It’s not active suppression most of the time, it’s willful negligence and underfunding. I got into the field hopeful, and left jaded.

              • SCB@lemmy.world
                link
                fedilink
                arrow-up
                1
                ·
                8 months ago

                It’s not active suppression most of the time,

                This is your initial claim, though.

                • sigmaklimgrindset@sopuli.xyz
                  link
                  fedilink
                  arrow-up
                  1
                  ·
                  8 months ago

                  No, my initial claim was:

                  Curing diabetes isn’t as profitable as selling insulin. That’s why it doesn’t get funded.

                  Then you opined that whoever comes up with a cure wins, which should be true in a perfect world. In fact, most researchers would agree with you.

                  Unfortunately, a lot of MBA’s in these pharma companies don’t see it that way, and my reply to you was trying to outline the realities of that. I focussed more on the patent-and-bury part because this is the one method less known to the public (and less used), but underfunding research that can do a public good but isn’t profitable is a common technique by corporations in research, regardless of the discipline.

                  My bad, I thought this was common knowledge, but it probably isn’t for people who aren’t in PhD/post-doc research roles.

    • SCB@lemmy.world
      link
      fedilink
      arrow-up
      1
      arrow-down
      3
      ·
      8 months ago

      This is the most boomer shit and it is so sad to see people still saying it

  • Downcount@lemmy.world
    link
    fedilink
    arrow-up
    17
    arrow-down
    1
    ·
    8 months ago

    In my understanding this could reverse the autoimmune reaction to Type 1 Diabetes not regrow the already killed β-cells.

      • Bransons404@lemmy.world
        link
        fedilink
        arrow-up
        3
        ·
        8 months ago

        It really would. I fear that anything remotely close to a “cure” would be thwarted by pharma because they profit so much from insulin.

        I switched jobs a few months ago, and had about 2 weeks without insurance. my insulin prescription was over $4k.

        I know that “pharma” can’t just shut something down… but I’m sure there’s some loophole

  • Chaos@lemmy.world
    link
    fedilink
    arrow-up
    10
    ·
    8 months ago

    Awesome, I have an autoimmune desease that can possibly paralyse me in future. I hope progress can continue 🙏

    • amio@kbin.social
      link
      fedilink
      arrow-up
      4
      ·
      8 months ago

      Not only that, it is a repost from three months ago. Not that OP would be expected to know, but it does take off a few “groundbreaking” points.

      • nymwit@lemm.ee
        link
        fedilink
        arrow-up
        2
        ·
        8 months ago

        I mean, it’s making it to human trials so seems a lot more real than most of these “kills cancer cells in a petri dish” sort of things.

        • amio@kbin.social
          link
          fedilink
          arrow-up
          2
          ·
          8 months ago

          What I mean is the actual article linked to is already months old. Also, that’s great, but it’s not out of the woods yet.

  • MisterChief@lemmy.world
    link
    fedilink
    arrow-up
    7
    ·
    8 months ago

    I remember seeing something on reddit about this earlier this year iirc. Definitely exciting and I certainly hope there is credence to this. Would love to see auto immune disorders go by the wayside in the next couple decades. Once they fix all the real bad ones I hope they make one for vitiligo, I’m tired of 70 spf sunblock and weird looking tans.

  • Chainweasel@lemmy.world
    link
    fedilink
    English
    arrow-up
    11
    arrow-down
    4
    ·
    8 months ago

    Sounds pretty advanced. I bet they won’t be able to activate the mind control chips until 6G cell services launch.